Jan 2009 to Aug 2013 InvestigatorGlaxoSmithKline Pharmaceuticals, Product Department
Jul 2003 to Jan 2009 Principal ScientistGlaxoSmithKline Pharmaceuticals, Strategic Department
Aug 2000 to Jun 2003 Principal ScientistAerotek
May 1997 to Aug 2000 Senior Research ChemistUniversity of Michigan Ann Arbor, MI Dec 1993 to Apr 1997 Research ChemistUniversity of Rochester Rochester, NY Jun 1987 to Nov 1993 Research Assistant
Education:
University of Michigan Feb 2002 Technology CorporationUniversity of Rochester Rochester, NY Ph.D in Physical ChemistryUniversity of Rochester Rochester, NY M.S. in Chemistry
Francis Ignatious - King of Prussia PA, US Linghong Sun - Collegeville PA, US Andrew Craig - Tonbridge, GB David Crowe - Tonbridge, GB Tim Ho - Tonbridge, GB Michael Millan - Tonbridge, GB
International Classification:
A61K 9/20 A61K 31/343
US Classification:
424464000, 514469000, 549467000
Abstract:
The present invention is directed to use of electrospinning, i.e. the process of making polymer nanofibers from either a solution or melt under electrical forces, to prepare stable, solid dispersions of amorphous drugs in polymer nanofibers. The present invention is also directed to the process of making solid dispersions of amorphous forms and compositions of rosiglitazone and its pharmaceutically acceptable salts.
Francis Ignatious - King of Prussia PA, US Linghong Sun - Collegeville PA, US
International Classification:
A61K 9/20
US Classification:
424464000
Abstract:
The present invention is directed to use of electrospinning, i.e. the process of making polymer nanofibers from either a solution or melt under electrical forces, to prepare stable, solid dispersions of amorphous drugs in polymer nanofibers.